4.7 Editorial Material

Combined Use of Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses Is a Powerful Diagnostic Tool of Active Tuberculosis

Journal

CLINICAL INFECTIOUS DISEASES
Volume 60, Issue 3, Pages 432-437

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciu795

Keywords

diagnosis; active tuberculosis disease; latent Mtb infection; functional profile; CD8 T cells

Funding

  1. NIAID NIH HHS [R01 AI083156] Funding Source: Medline
  2. NIH HHS [P51 OD011132] Funding Source: Medline

Ask authors/readers for more resources

Immune-based assays are promising tools to help to formulate diagnosis of active tuberculosis. A multiparameter flow cytometry assay assessing T-cell responses specific to Mycobacterium tuberculosis and the combination of both CD4 and CD8 T-cell responses accurately discriminated between active tuberculosis and latent infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin

Ivana Palucci, Alessandro Salustri, Flavio De Maio, Maria del Carmen Pereyra Boza, Francesco Paglione, Michela Sali, Luca Occhigrossi, Manuela D'Eletto, Federica Rossin, Delia Goletti, Maurizio Sanguinetti, Mauro Piacentini, Giovanni Delogu

Summary: This study aimed to test the potential activity of cysteamine and cystamine against Mycobacterium abscessus. The results showed that these drugs restricted the growth of M. abscessus in human macrophages and had enhanced activity when combined with amikacin. The treatment with these drugs was more effective against MAB-S infection and reduced the inflammatory response triggered by MAB-R infection.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection

Munyaradzi Musvosvi, Huang Huang, Chunlin Wang, Qiong Xia, Virginie Rozot, Akshaya Krishnan, Peter Acs, Abhilasha Cheruku, Gerlinde Obermoser, Alasdair Leslie, Samuel M. Behar, Willem A. Hanekom, Nicole Bilek, Michelle Fisher, Stefan H. E. Kaufmann, Gerhard Walzl, Mark Hatherill, Mark M. Davis, Thomas J. Scriba

Summary: In this study, single-cell and bulk T-cell receptor (TCR) sequencing and the GLIPH2 algorithm were used to analyze M. tuberculosis-specific sequences in two longitudinal cohorts. The findings identified T-cell similarity groups associated with control of infection or progression to disease, and proposed antigens recognized by T-cell similarity groups associated with infection control as high-priority targets for future vaccine development.

NATURE MEDICINE (2023)

Article Cell Biology

Expression of specific HLA class II alleles is associated with an increased risk for active tuberculosis and a distinct gene expression profile

Leila Y. Y. Chihab, Rebecca Kuan, Elizabeth J. J. Phillips, Simon A. A. Mallal, Virginie Rozot, Mark M. M. Davis, Thomas J. J. Scriba, Alessandro Sette, Bjoern Peters, Cecilia S. Lindestam S. Arlehamn, SATVI Study Group

Summary: Specific HLA alleles have been identified as associated with susceptibility to active tuberculosis (TB), with lower expression of these alleles being linked to a decreased Mtb-specific T cell response and a specific gene expression signature.
Article Immunology

Meeting report: 6th Global Forum on Tuberculosis Vaccines, 22-25 February 2022, Toulouse, France

Carly Young, Sara Suliman, Virginie Rozot, Simon C. Mendelsohn

Summary: Safe, effective, and accessible vaccines are urgently needed to end tuberculosis (TB) by 2030. The 6th Global Forum on TB Vaccines, hosted by Toulouse, France, highlighted the progress and gaps in TB vaccine research and development. The meeting discussed the advancement of TB vaccines into late-stage clinical trials, the diversification of the TB vaccine pipeline, increasing political and community support, and the impact of the ongoing COVID-19 pandemic on TB vaccine development.

VACCINE: X (2023)

Editorial Material Infectious Diseases

World Tuberculosis Day 2023 theme Yes! We Can End TB!

Delia Goletti, Seif Al-Abri, Giovanni Battista Migliori, Rhea Coler, Catherine Wei Min Ong, Susanna Maria Roberta Esposito, Marina Tadolini, Alberto Matteelli, Daniela Cirillo, Elisa Nemes, Alimuddin Zumla, Eskild Petersen

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Biochemistry & Molecular Biology

Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose

Serena Ruggieri, Alessandra Aiello, Carla Tortorella, Assunta Navarra, Valentina Vanini, Silvia Meschi, Daniele Lapa, Shalom Haggiag, Luca Prosperini, Gilda Cuzzi, Andrea Salmi, Maria Esmeralda Quartuccio, Anna Maria Gerarda Altera, Anna Rosa Garbuglia, Tommaso Ascoli Bartoli, Simonetta Galgani, Stefania Notari, Chiara Agrati, Vincenzo Puro, Emanuele Nicastri, Claudio Gasperini, Delia Goletti

Summary: This study investigated the antibody and T-cell immune responses in multiple sclerosis patients (PwMS) undergoing different disease-modifying treatments (DMTs) after receiving the two-dose schedule of a COVID-19 mRNA vaccine. The results showed a significant decrease in seroconversion rate and anti-receptor-binding domain (RBD)-IgG titers from the first dose to 24 weeks later, and a significant increase after the booster dose. The booster dose improved both humoral and cell-mediated immune responses, especially in PwMS, highlighting the need for tailored strategies for immunocompromised patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Immunology

Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control

Rosemary V. Swanson, Ananya Gupta, Taylor W. Foreman, Lan Lu, Jose Alberto Choreno-Parra, Stanley Kimbung Mbandi, Bruce A. Rosa, Sadia Akter, Shibali Das, Mushtaq Ahmed, Maria de la Luz Garcia-Hernandez, Dhiraj K. Singh, Ekaterina Esaulova, Maxim N. Artyomov, Jennifer Gommerman, Smriti Mehra, Joaquin Zuniga, Makedonka Mitreva, Thomas J. Scriba, Javier Rangel-Moreno, Deepak Kaushal, Shabaana A. Khader

Summary: Khader and colleagues demonstrate that Mtb-specific B cells play a vital role in recruiting T-FH cells into follicular-like structures within lung granulomas to control Mtb bacilli. However, specific antibodies and conventional properties of B cells are not essential for this process. Understanding the mechanisms of protection during TB is crucial due to its global impact as a leading cause of death.

NATURE IMMUNOLOGY (2023)

Article Multidisciplinary Sciences

Virome-wide detection of natural infection events and the associated antibody dynamics using longitudinal highly-multiplexed serology

Erin J. Kelley, Sierra N. Henson, Fatima Rahee, Annalee S. Boyle, Anna L. Engelbrektson, Georgia A. Nelson, Heather L. Mead, N. Leigh Anderson, Morteza Razavi, Richard Yip, Jason T. Ladner, Thomas J. Scriba, John A. Altin

Summary: Current methods for detecting infections are limited in their ability to query multiple agents and provide immune response information. In this study, the authors use a novel approach to monitor infection events in the human virome by analyzing temporally coordinated changes in highly-multiplexed antibody measurements from longitudinal blood samples. They identify over 650 events across 48 virus species and observe strong epidemic effects. This approach provides a high-resolution view of viral/host dynamics and has implications for immunology and epidemiology research.

NATURE COMMUNICATIONS (2023)

Article Immunology

NK-like CD8+?? T cells are expanded in persistent Mycobacterium tuberculosis infection

Roshni Roy Chowdhury, John R. Valainis, Megha Dubey, Lotta von Boehmer, Elsa Sola, Julie Wilhelmy, Jing Guo, Oliver Kask, Mane Ohanyan, Meng Sun, Huang Huang, Xianxi Huang, Patricia K. Nguyen, Thomas J. Scriba, Mark M. Davis, Sean C. Bendall, Yueh-hsiu Chien

Summary: Examined the response of gamma delta T cells in acute versus chronic phases of tuberculosis infection and found an expansion of CD8+ gamma delta T cells with memory inflation features in chronic infection. These cells are hyporesponsive to T cell receptor signaling but can mount cytotoxic responses mediated by CD16. Furthermore, CD8+ gamma delta T cells also expand in other chronic inflammatory conditions, suggesting similar effector programs and differentiation fates driven by persistent antigen exposure.

SCIENCE IMMUNOLOGY (2023)

Review Pathology

Research tests for the diagnosis of tuberculosis infection

Tonino Alonzi, Federica Repele, Delia Goletti

Summary: Despite efforts, tuberculosis remains a major global health threat with a quarter of the world's population estimated to be infected by Mycobacterium tuberculosis (Mtb). Currently, there is no gold standard test for diagnosing tuberculosis infection (TBI) although new methodologies have been attempted.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2023)

Article Cell Biology

The ubiquitin ligase TRIM32 promotes the autophagic response to Mycobacterium tuberculosis infection in macrophages

Alessandra Romagnoli, Martina Di Rienzo, Elisa Petruccioli, Carmela Fusco, Ivana Palucci, Lucia Micale, Tommaso Mazza, Giovanni Delogu, Giuseppe Merla, Delia Goletti, Mauro Piacentini, Gian Maria Fimia

Summary: In this study, the role of TRIM proteins in the host response to Mtb infection was investigated. TRIM32 was identified as a novel factor involved in the intracellular response to Mtb infection, promoting autophagy-mediated Mtb degradation. Silencing TRIM32 expression in THP1 cells resulted in increased intracellular growth of Mtb, impaired Mtb ubiquitination, reduced recruitment of autophagy proteins to Mtb, and decreased autophagosome formation. These findings suggest that TRIM32 plays an important role in the host response to Mtb infection and could be a promising target for tuberculosis therapies.

CELL DEATH & DISEASE (2023)

Article Multidisciplinary Sciences

Integrated analysis of whole blood oxylipin and cytokine responses after bacterial, viral, and T cell stimulation reveals new immune networks

Etienne Villain, Aurelie Chanson, Malwina Mainka, Nadja Kampschulte, Pauline Le Faouder, Justine Bertrand-Michel, Marion Brandolini-Bulon, Bruno Charbit, Munyaradzi Musvosvi, Nicole Bilek, Thomas J. Scriba, Lluis Quintana-Murci, Nils Helge Schebb, Darragh Duffy, Cecile Gladine

Summary: Oxylipins have been identified as major immunomodulating mediators that play a crucial role in inflammation regulation. Our study characterized the oxylipin-driven inflammatory responses to different stimuli and their relationships with cytokine responses. The integration of oxylipin and cytokine responses revealed new immune networks and provided insights into the regulation of inflammation.

ISCIENCE (2023)

Article Biochemical Research Methods

TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs

Raphael Genolet, Sara Bobisse, Johanna Chiffelle, Marion Arnaud, Remy Petremand, Lise Queiroz, Alexandra Michel, Patrick Reichenbach, Julien Cesbron, Aymeric Auger, Petra Baumgaertner, Philippe Guillaume, Julien Schmidt, Melita Irving, Lana E. Kandalaft, Daniel E. Speiser, George Coukos, Alexandre Harari

Summary: T cell receptor (TCR) technologies are essential in the clinical management of cellular immunity, but current methods for repertoire analyses and TCR cloning lack sensitivity and reliability. This study introduces SEQTR, a high-throughput approach that is more sensitive and accurate in analyzing human and mouse repertoires, enabling more reliable capture of the complexity of TCR repertoires. Additionally, a TCR cloning strategy is presented for efficient discovery, cloning, screening, and engineering of tumor-specific TCRs.

CELL REPORTS METHODS (2023)

No Data Available